We are pleased to inform you that ELISA/ACT® Biotechnologies (EAB) LLC has transitioned the dental and orthopedic materials testing to the Lymphocyte Response Assay (LRA) platform. The past two years have provided us with a better understanding of the details of dental and orthopedic materials testing and we are now confident that we can use the LRA process to evaluate these immune responses.
This transition has significantly improved the specificity and reproducibility of this testing using the comprehensive LRA methodology.
Click here to see what is in the panels.
Click here to see a Q&A about the panels.
Please email or call our client services team at 800-553-5472 with any questions or concerns. Our team is here to help and guide you during this process.